ClinicalTrials.gg
RecruitingNCT04312269Updated May 27, 2026

Combining MyoCI With Memory Reactivation to Improve Motor Recovery After Stroke

An interventional study of Targeted Memory Reactivation (TMR) in Stroke, sponsored by Northwestern University. Recruiting at 1 site in United States. Open to participants aged 21 Years to 100 Years. Per ClinicalTrials.gov, last updated 2026-05-27.

Sponsored by Northwestern University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Feb 2020; still recruiting 6 years 8 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
21 Years to 100 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 24 studies in Stroke by Northwestern University — 6 open to participants now, 8 under way, none of them phase 3. Stroke · Northwestern University.

Planned enrollment
8th of 20
70 · median 52
Started
2020
with 1 other
No phase
17 of 24
5 open now
Registered
18th of 24
by date

Among the 24 studies in Stroke by Northwestern University, this one is the 8th largest by planned enrollment of the 20 interventional ones that give a count, is one of 2 that started in 2020, is one of 17 with no phase, and was the 18th registered.

Stroke

8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.

Browse Stroke studies →

Open to participants now

6 of the 24 studies in Stroke by Northwestern University are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 6 open studies →

Where they have run

Who these studies take

Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.

This study: 21 Years to 100 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 24 studies in Stroke by Northwestern University, or all of them as a file.
02

Study summary

This study will examine the combination of myoelectric computer interface (MyoCI) training with targeted memory reactivation (TMR) in chronic stroke survivors. The study aims to determine whether this training-plus-sleep combination will generalize to improve arm motor function over an extended training protocol in stroke survivors.

03

Conditions studied

  • Stroke

Browse trials for

Keywords

  • Sleep
04

Who can participate

Ages eligible
21 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age at enrollment is 21 or older
  • Hemiparesis from first ever stroke affecting arm movement at least 6 months prior to screening
  • Severe to moderate motor impairment (FMA-UE of 7-40)
  • At least some voluntary shoulder and elbow muscle activation

Exclusion criteria

Exclusion Criteria:

  • Inability to follow instructions of the MyoCI task
  • Visual impairment (such as hemianopia) preventing full view of screen
  • Anesthesia or neglect in the affected arm, or visual hemineglect (score of 2 on the NIH Stroke Scale Extinction and Inattention subtest)
  • Participation in another study on the affected arm within 6 weeks of enrollment or any pharmacological study
  • Inability to understand or follow commands in English due to aphasia or other reason
  • Diffuse or multifocal infarcts in both hemispheres
  • Substantial arm pain preventing participation for 90 minutes a day
  • Spasticity treatment (pharmacological or Botox) within last 3 months
  • Ferromagnetic implants that are MRI incompatible
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
70 participants (estimated)

Study arms

  • Experimental
    All phase TMR

    TMR during every stage of sleep

    Other: Targeted Memory Reactivation (TMR)

  • Experimental
    Slow-wave sleep (SWS) only TMR

    TMR during slow-wave sleep only

    Other: Targeted Memory Reactivation (TMR)

  • Experimental
    Reduced frequency TMR

    TMR during only subset of sessions

    Other: Targeted Memory Reactivation (TMR)

  • Sham comparator
    Sham TMR

    Patients receive no TMR

    Other: Targeted Memory Reactivation (TMR)

Interventions

  • OtherTargeted Memory Reactivation (TMR)

    Targeted memory reactivation (TMR) refers to the process of playing audio cues associated with specific learned material quietly during sleep in order to strengthen consolidation of specific memories during sleep.

06

What researchers measure

Primary outcomes

  1. Wolf Motor Function Test (WMFT)

    The WMFT evaluates upper extremity function on a continuous scale. It measures the time it takes to perform 15 different tasks, with a time limit of 120 s per task.

    Time frame: change from baseline at 6 weeks

Secondary outcomes

  1. Fugl-Meyer Assessment of Upper Extremity (UE) Motor Function

    The FMA-UE is a measure of impairment. Maximum score is 66 on the motor function portion. Items are scored on a 3-point ordinal scale.

    Time frame: change from baseline at 6 weeks

  2. Fugl-Meyer Assessment of Upper Extremity (UE) Motor Function

    The FMA-UE is a measure of impairment. Maximum score is 66 on the motor function portion. Items are scored on a 3-point ordinal scale.

    Time frame: change from baseline at 10 weeks

  3. Motor Activity Log (MAL)

    The MAL is a validated measure of home-based arm function, both quantity and quality of use in 30 different activities of daily living.

    Time frame: change from baseline at 6 weeks

  4. Motor Activity Log (MAL)

    The MAL is a validated measure of home-based arm function, both quantity and quality of use in 30 different activities of daily living.

    Time frame: change from baseline at 10 weeks

  5. Modified Ashworth Scale

    The Modified Ashworth Scale is a measure of spasticity, which is graded on a scale of 0-4 per joint tested.

    Time frame: change from baseline at 6 weeks

  6. Modified Ashworth Scale

    The Modified Ashworth Scale is a measure of spasticity, which is graded on a scale of 0-4 per joint tested.

    Time frame: change from baseline at 10 weeks

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — Clinical functional outcomes and analyzed EMG (co-activation) will be uploaded and shared upon publication.

Supporting information: Analytic code

Time frame: IPD and associated analytic code will be made available upon publication of research results and will remain available for the duration of the funded project.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2020 (actual). Primary completion is estimated for Jan 2027, 83 months after the start.

Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 83 months is above that.

Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 9, 2020
First posted
Mar 18, 2020
StartActual
Feb 25, 2020
Primary completionEst.
Jan 30, 2027
CompletionEst.
Jan 30, 2027
Last update
May 27, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04312269
Responsible party
Marc Slutzky (Associate Professor, Northwestern University) — Principal investigator
First posted
Mar 18, 2020
Start date
Feb 25, 2020
Primary completion
Jan 30, 2027 (estimated)
Completion
Jan 30, 2027 (estimated)
Last update
May 27, 2026

Study contacts

Marc W Slutzky, MD/PhD
Contact
mslutzky@northwestern.edu
312-503-4653
Marc W Slutzky, MD/PhD
principal investigator · Northwestern University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion